AstraZeneca Sees 2030 Goal on Track as Cancer Drugs Drive Growth
(feeds.content.dowjones.io)
1.
2.
3.
4.
Gilead to Buy German Biotech Tubulis for $3 Billion for Experimental Cancer Drugs
(feeds.content.dowjones.io)
5.
Revolution Medicines Draws Takeover Interest
(feeds.content.dowjones.io)
6.
AbbVie Near Deal for Revolution Medicines
(feeds.content.dowjones.io)
Today's top topics:
openai
google
hugging face
android authority
apple
sk hynix
anthropic
iphone
humanoid robots
samsung